Endocrine Society announces departure of CEO, Barbara Byrd Keenan

The Endocrine Society has announced the departure of CEO Barbara Byrd Keenan, FASAE, CAE, effective February 5, 2020. Keenan had served in the role since 2014.

“Under Barbara’s leadership, we’ve expanded the reach and influence of the Endocrine Society, and experienced growth and increased engagement of our staff, Board, and members,” said Endocrine Society President E. Dale Abel, M.D., Ph.D., of the University of Iowa, Carver College of Medicine, Iowa City, Iowa. “On behalf of the Board, we extend our appreciation to Barbara for her years of service and wish her well in her future endeavors.”

Under Keenan’s leadership the Society accelerated its global engagement, repositioned its suite of publications, implemented a new strategic plan, and forged many new strategic partnerships. In the past six years the Society won 10 awards for education, finance, program development, communications and diversity.

“Barbara has left us well positioned for continued growth,” said Abel, “and we are looking forward to expanding our role as the world’s leading endocrine society.”

The Endocrine Society Board of Directors will engage in a formal search process for a Chief Executive Officer.

About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.